Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

OBJECTIVE Type 2 diabetes is a common risk factor for the development of chronic kidney disease (CKD). Enhanced de novo collagen type VI (COL VI) formation has been associated with renal fibrosis and CKD. We investigated the hypothesis that PRO-C6, a product specifically generated during COL VI formation, is prognostic for adverse outcomes in patients with type 2 diabetes and microalbuminuria. RESEARCH DESIGN AND METHODS In a prospective, observational study, we measured PRO-C6 in the serum (S-PRO-C6) and urine (U-PRO-C6) of 198 patients with type 2 diabetes and microalbuminuria without symptoms of coronary artery disease. Patients were followed for a median of 6.5 years, and end points were a composite of cardiovascular events (n = 38), all-cause mortality (n = 26), and reduction of estimated glomerular filtration rate (eGFR) of >30% (disease progression [n = 42]). Cox models were unadjusted and adjusted for the conventional risk factors of sex, age, BMI, systolic blood pressure, LDL cholesterol, smoking, HbA1c, plasma creatinine, and urinary albumin excretion rate. RESULTS Doubling of S-PRO-C6 increased hazards for cardiovascular events (hazard ratio 3.06 [95% CI 1.31–7.14]), all-cause mortality (6.91 [2.96–16.11]), and disease progression (4.81 [1.92–12.01]). Addition of S-PRO-C6 to a model containing conventional risk factors improved relative integrated discrimination by 22.5% for cardiovascular events (P = 0.02), 76.8% for all-cause mortality (P = 0.002), and 53.3% for disease progression (P = 0.004). U-PRO-C6 was not significantly associated with any of the outcomes. CONCLUSIONS S-PRO-C6 generated during COL VI formation predicts cardiovascular events, all-cause mortality, and disease progression in patients with type 2 diabetes and microalbuminuria.

[1]  C. Soeller,et al.  Increased collagen within the transverse tubules in human heart failure , 2017, Cardiovascular research.

[2]  M. Karsdal,et al.  Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease , 2017, PloS one.

[3]  A. Vlahou,et al.  A urinary proteome‐based classifier for the early detection of decline in glomerular filtration , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  O. Pedersen,et al.  Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial , 2016, Diabetologia.

[5]  H. Parving,et al.  Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria , 2016, Diabetologia.

[6]  M. Karsdal,et al.  Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes , 2016, Diabetologia.

[7]  M. Karsdal,et al.  Collagen Type III and VI Turnover in Response to Long-Term Immobilization , 2015, PloS one.

[8]  P. Bonaldo,et al.  Collagen VI at a glance , 2015, Journal of Cell Science.

[9]  H. Parving,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[10]  M. Karsdal,et al.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[11]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[12]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States, 1990-2010. , 2014, The New England journal of medicine.

[13]  M. Karsdal,et al.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? , 2014, Fibrogenesis & tissue repair.

[14]  J. Varga,et al.  Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction , 2014, Nature Communications.

[15]  Desmond E. Williams,et al.  Changes in diabetes-related complications in the United States. , 2014, The New England journal of medicine.

[16]  J. Sowers,et al.  Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system , 2013, Hormone molecular biology and clinical investigation.

[17]  M. Joffe,et al.  Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[18]  D. Weihrauch,et al.  Absence of Type VI Collagen Paradoxically Improves Cardiac Function, Structure, and Remodeling After Myocardial Infarction , 2012, Circulation research.

[19]  E. Bonora,et al.  Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. , 2012, American Society of Nephrology. Clinical Journal.

[20]  Youhua Liu Cellular and molecular mechanisms of renal fibrosis , 2011, Nature Reviews Nephrology.

[21]  H. Parving,et al.  Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[23]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[24]  M. Girolami,et al.  Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease* , 2010, Molecular & Cellular Proteomics.

[25]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[26]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[27]  H. Folkesson,et al.  Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. , 2006, American journal of physiology. Heart and circulatory physiology.

[28]  G. Magro,et al.  Immunohistochemical distribution of type VI collagen in developing human kidney , 1996, The Histochemical Journal.

[29]  Zhongxin Zhang,et al.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.

[30]  W. Hornebeck,et al.  An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. , 2004, Critical reviews in oncology/hematology.

[31]  T. Aigner,et al.  Collagens--structure, function, and biosynthesis. , 2003, Advanced drug delivery reviews.

[32]  U. Schlötzer-Schrehardt,et al.  The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion. , 2002, Biochemical and biophysical research communications.

[33]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[34]  M. Endoh,et al.  Analysis of prognostic predictors in idiopathic membranous nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  R. Klein,et al.  The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. , 2000, Archives of internal medicine.

[36]  M. Harris,et al.  Diabetes and decline in heart disease mortality in US adults. , 1999, JAMA.

[37]  K. Marder,et al.  Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis. , 1995, Clinical nephrology.

[38]  R. Timpl,et al.  Immunohistochemical localization of collagen VI in diabetic glomeruli. , 1994, Kidney international.

[39]  T. Crowley,et al.  Myocardial glycoproteins in diabetes: type VI collagen is a major PAS-reactive extracellular matrix protein. , 1992, Journal of molecular and cellular cardiology.

[40]  D. Schuppan,et al.  Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease , 1992, Hepatology.

[41]  Y Okada,et al.  Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[42]  H. D. de Wardener,et al.  Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. , 1968, Lancet.